PHR
ANALYST COVERAGE25 analysts
BUY
+171.3%upside to target
L $10.00
Med $25.00consensus
H $33.00
Buy
1976%
Hold
624%
19 Buy (76%)6 Hold (24%)0 Sell (0%)
Full report →
PRICE
Prev Close
8.77
Open
8.85
Day Range8.81 – 9.15
8.81
9.15
52W Range7.77 – 32.76
7.77
32.76
6% of range
VOLUME & SIZE
Avg Volume
1.9M
FUNDAMENTALS
P/E Ratio
227.0x
Premium valuation
EPS (TTM)
Div Yield
No dividend
Beta
1.68
High vol
TECHNICAL
RSI (14)
39
Bearish momentum
Upcoming Events
EEarnings Report
Tomorrow
May 19
DEx-Dividend
In 88 days
Aug 14
PDividend Pay
In 105 days
Aug 31
Key MetricsTTM
Market Cap$543.22M
Revenue TTM$480.59M
Net Income TTM$2.31M
Free Cash Flow$63.83M
Gross Margin61.3%
Operating Margin0.5%
Net Margin0.5%
Return on Equity0.7%
Return on Assets0.3%
Debt / Equity0.30
Current Ratio1.53
EPS TTM$0.04

PHR News

About

leading healthcare organizations choose phreesia to revolutionize their point of service. in medical groups of all sizes, phreesia’s flexible and scalable platform drives tangible results across administrative, financial and clinical operations so that staff can focus on providing exceptional patient care.

Industry
Data Processing, Hosting, and Related Services
CEO
Chaim Indig
David LinetskyPresident of Network Solutions
Maureen McKinneyVice President of Corporate Communications
Yvonne HuiSenior VP & Chief Accounting Officer
Balaji GandhiChief Financial Officer
Chaim IndigCo-Founder, Chief Executive Officer & Director
Evan RobertsCo-Founder & President of Provider Solutions
Jack CallahanChief Technology Officer
Nick KemskeChief Information Security Officer
Allison C. HoffmanGeneral Counsel & Secretary
Amy Beth VanDuynSenior Vice President of Human Resources
Briana KearneyVice President of Marketing